Compare BIO & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HXL |
|---|---|---|
| Founded | 1952 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.6B |
| IPO Year | N/A | 1994 |
| Metric | BIO | HXL |
|---|---|---|
| Price | $278.96 | $92.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $358.50 | $81.73 |
| AVG Volume (30 Days) | 289.2K | ★ 1.3M |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,893,900,000.00 |
| Revenue This Year | $2.31 | $10.20 |
| Revenue Next Year | $3.10 | $12.65 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $211.43 | $45.28 |
| 52 Week High | $343.12 | $94.46 |
| Indicator | BIO | HXL |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 68.84 |
| Support Level | $266.71 | $80.25 |
| Resistance Level | $290.01 | $93.14 |
| Average True Range (ATR) | 9.32 | 2.53 |
| MACD | 0.34 | 0.34 |
| Stochastic Oscillator | 57.28 | 81.22 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.